StockData
BioMarin Pharmaceutical Inc logo

BioMarin Pharmaceutical Inc (BMRN) stock

BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30104% above fair value
$61.43+2.92 (+4.99%)

Close on Nov 18, 2026Market cap $11.89BP/E 161.7Yield –

BioMarin Pharmaceutical pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

BioMarin Pharmaceutical's pe ratio was 153.5× on Nov 11, 2026, against 21.1× a year earlier. Over the last 5 years it ranged from 15.9× to 478.1×, with a median of 76.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026153.5×+131.1
2025Dec 31, 202522.4×−16.9
2024Dec 31, 202439.4×−85.9
2023Dec 29, 2023125.2×−121.2
2022Dec 30, 2022246.4×+227.8
2021Oct 29, 202118.6×−1.5
2020Dec 31, 202020.1×−3.0
2011Oct 31, 201123.0×+7.5
2010Dec 31, 201015.6×−49.3
2009Dec 31, 200964.9×–

More BioMarin Pharmaceutical figures

See a number that looks wrong?